89 startups and 28 open roles on the map.
Xaira Therapeutics
South San Francisco
an integrated biotechnology company driving advances in AI to transform how we treat disease.
Plasmidsaurus
South San Francisco
Plasmidsaurus accelerates cures and a healthier planet by boosting productivity of scientists using DNA tools through 10 24/7 labs, serving Nobel Prize winners, with rapid DNA-sample logistics under 12 hours and a goal to save 4 million hou
Feltsense
South San Francisco
Feltsense builds autonomous agents to run entire businesses, aiming to move beyond chat to autonomous management. Backed by $5.1M funding from investors, it operates at the intersection of autonomous systems and applied AI and is scaling in
Deep Origin
South San Francisco
Accelerating R&D to untangle the complexity of life and discover drugs
AeroVect
South San Francisco
AeroVect develops airport automation systems that use embodied AI to manage baggage and cargo logistics on the airfield.
insitro
South San Francisco
Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.
Cellares
South San Francisco
Accelerating Access to Life-Saving Cell Therapies
Stripe
South San Francisco
Stripe is a global technology company that builds economic infrastructure for the internet, serving startups and public companies from San Francisco. Notable for raising $6.5 billion at a $50 billion valuation in March 2023.
Invisible AI
South San Francisco
Invisible AI applies computer vision to manufacturing environments and plant operations, using AI to provide recommendations that improve productivity, quality, and safety.
Neurona Therapeutics
South San Francisco
Neurona Therapeutics is a biotherapeutics company that focuses on developing cell-based therapies to address neurological disorders.
Encoded Therapeutics
South San Francisco
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Tizona Therapeutics
South San Francisco
Tizona develops next-generation immunotherapies